CBD for Tourette’s syndrome. How effective is CBD for TS? What is the research evidence? Learn more about Happy Garden high-quality products. Medical Marijuana TAA Position Statement on the Use of Medical Marijuana for Tourette Syndrome The Tourette Association of America (TAA) is the leading national non-profit organization in the
CBD for Tourette’s Syndrome
Today’s quest for unconventional solutions to combat many serious neurological disorders has resulted in some scientific evidence. Using cannabinoids or CBD for Tourette’s syndrome (TS) is one of them.
Cannabidiol (CBD) is thought to bring non-psychoactive effects, which may help mental disorders, such as Tourette’s syndrome. In addition, as a chemical compound derived from cannabis and hemp plants, CBD has proved possible therapeutic application in neuropsychiatric illnesses.
In June 2018, the FDA approved a CBD-based medicine for epilepsy, opening doors for research in treatments associated with CBD. However, due to the lack of randomized trials and data, the scientific evidence is insufficient to place CBD among traditional medications for TS.
As for THC, which is an opposite element of cannabis, known for its psychoactive effect, a small number of case studies in adults demonstrate that THC may help reduce tics and other symptoms without causing significant side effects. Nevertheless, similar to CBD, more research and data are needed to approve THC and CBD for Tourette’s syndrome.
THC and CBD for Treating Tourette’s Syndrome
CBD in combination with THC showed excellent results. For example, according to a 2016 report , a male patient was given a daily dosage of Sativex (THC and CBD), and he showed more than an 80% reduction of motor and vocal tics after two weeks of treatment.
In a 2017 study , a 19-year old patient was given medicinal cannabis at a dose of 0.1 mg daily. After eight months, the symptoms improved, including speech fluency and other tics. After inhaling cannabis, positive effects remained for about an hour and a half. Although the result didn’t last long, the overall effect was impressive. A patient described a feeling of “high” only at the beginning of the trial.
Can I Try CBD for Tourette’s Syndrome
In our view, it does make sense to try CBD for Tourette’s Syndrome, and that is for a reason. Available conventional treatments for TS are meant to mitigate symptoms, but they can’t eliminate tics entirely. TS patients usually take antipsychotics that come with many side effects, such as sedation, weight gain, metabolic changes, and acute dyskinesia. On the other hand, CBD with low levels of THC is less likely to trigger known side effects like:
- Dry mouth
- Appetite change
So in light of this, some patients with TS unsatisfied with traditional treatment due to adverse side effects opt for alternatives, namely cannabidiol treatment. Besides, the World Health Organization (WHO) has announced that CBD is well-tolerated in humans and doesn’t create any dependence .
Since recreational marijuana is legalized in many states, many people with TS choose to use CBD formulations with THC concentration for self-medication without informing their doctor.
Yet, we urge people with TS never to use CBD products without consulting their health care provider. Despite CBD safety, there’s evidence that cannabidiol may cause adverse side effects (e.g., liver damage) when interacting with other medications a TS patient may take.
How CBD Treatment Compares to Other Complementary Treatments
There are many alternative treatments of TS for controlling tics. For example, hypnotherapy is meant to enhance focus on positive thinking and provide relaxation.
When it comes to anxiety, antidepressants, such as imipramine, are known to improve depression. In the same way, CBD is believed to have the same qualities that can alleviate anxiety , bring stress relief , and contribute to relaxation.
A case review on a patient with PTSD showed that CBD transformed sleep quality. In addition, CBD, especially in the form of oil, decreased anxiety. In another clinical research , more than 70 adults were evaluated. Consequently, their anxiety and sleep levels improved.
This data suggests that CBD may benefit adults with Tourette’s syndrome.
Which Type of CBD Product to Choose?
You will find three types of CBD on Happy Garden online shelves: broad-spectrum, full-spectrum, and isolates.
The most in-demand types are full-spectrum products because they contain THC, which is considered to play a therapeutic role in patients with TS. So CBD in synergy with THC can be more effective than if used separately, like in isolate oils.
Daily CBD Dosage
Although there are no official dosage instructions, studies revealed that doses ranging between 300 mg to 600 mg of CBD could decrease anxiety and sadness scores in people.
A daily dose of 160 mg of cannabidiol oil helped to have a better sleep. At the same time, even doses hitting 1,500 mg per day are reported well-tolerated by humans.
The best practice is always to start with a small CBD oil dosage, see how your body reacts, and gradually increase the amount.
Intake Method of CBD for Tourette’s Syndrome
CBD oils and tinctures are easy to dose because they have droppers. The oil can be added to food or taken sublingually.
The relaxation effect can be achieved using balms, salves, and creams. These are primarily used for relieving pain and anxiety.
Meantime, Happy Garden offers CBD edibles, like gummies. If you are a novice CBD user, you can add them to foods and beverages. Interestingly, cannabidiol doesn’t cause munchies .
What You Should Know: THC Risk in CBD Products
Many people wrongly believe that CBD products with THC will make them “high.” However, this isn’t true. According to federal law, up to 0.3% of THC concentration in CBD products is considered legal, so it’s out of this concern.
But there’s another side of the coin. If you live in a state like California or Colorado, where recreational cannabis or marijuana is legal, you should know that smoking marijuana and consuming CBD oil with the approved level of THC is not the same.
Marijuana users can become addicted. Other harmful effects are short-term memory, the reaction to time, etc. Besides, marijuana smokers are exposed to potential lung cancer as tobacco smokers.
We are highlighting this because we don’t want you to take advantage of the legality of recreational marijuana to experiment on Tourette’s syndrome. To be safe, use high-quality CBD products with allowed THC levels that won’t cause addiction and health problems mentioned above.
What About CBD for Tourette’s Syndrome in Minors?
There are three case studies treating TS with cannabis, and one of them is related to a 12-year-old boy who was given only 1% CBD and 22% THC, equal to 4.4 mg THC. The report said there was a “marked tic reduction and improvement in premonitory urges without any side effects.” However, the trials mainly study the THC properties, so we see less evidence of using cannabidiol in treating TS for minors. For this reason, we do not recommend CBD for young adults with TS. Or, you should discuss the possibility of using cannabidiol with your child’s doctor.
On the flip side, teens often use CBD as homeopathic therapy for depression , pain , acne , and insomnia . Although CBD doesn’t appear dangerous, parents should be aware that it isn’t a fully-investigated field and thus, may lead to serious adverse effects, like nausea, seizures, loss of consciousness, vomiting, and altered mental state.
How to Purchase the Best CBD for Tourette’s?
If you are looking to mitigate symptoms of Tourette’s syndrome, and you intend to try CBD products, look for these signs:
- 100% Organic products;
- Full-spectrum CBD that provides entourage effect
- CO2 extraction with no harmful chemicals
- Quality certificates from third-party
Our CBD products comply with the law, but you should see your physician before using CBD for Tourette’s syndrome.
TAA Position Statement on the Use of Medical Marijuana for Tourette Syndrome
The Tourette Association of America (TAA) is the leading national non-profit organization in the United States working to make life better for all people affected by Tourette Syndrome and Tic Disorders. As part of that mission the TAA has encouraged and funded research into all aspects of Tourette Syndrome including pharmacological, behavioral, and alternative treatments and therapies.
Inquiries about the use of medical marijuana (cannabis) to alleviate the symptoms of Tourette Syndrome have been on the rise. While some adult members of our community have reported reduced tics when using medical marijuana, others have reported adverse reactions or no effect at all. Medical marijuana has two primary chemical components: Delta-9- tetrahydrocannabinol (THC) and Cannabidiol (CBD). Medical marijuana and cannabis-based medications that include THC and cannabis extracts have been reported to reduce symptoms of Tourette Syndrome in small scientific studies, patient reports, and anecdotal case reports. They are currently used to treat adult patients in Germany, Israel and Canada. There is insufficient data to support that CBD, without the addition of THC, is an effective treatment for Tourette Syndrome.
CBD-based oils, capsules, edibles and other formulations have become widely used over the last decade and are available throughout the country and on line. One CBD based medicine was approved in June 2018 by the FDA specifically to treat two rare forms of epilepsy, making it the first federally sanctioned medical use for CBD in the United States. The FDA has supported research of CBD-based medications and the NIH database reflects myriad studies of CBD as a potential treatment for neurological and neuropsychiatric disorders including epilepsy, Parkinson’s Disease, dyskinesia, dystonia, and anxiety. Although there is no
evidence that CBD alone is effective in treating Tourette Syndrome, anxiety is known to increase the frequency and severity of tics and testimonials for CBD as an effective anxiety reducing treatment are numerous.
To better understand the role of medical marijuana in treating Tourette Syndrome and Tic Disorders, the TAA formed a Cannabis Consortium comprised of leading clinicians and researchers in the field. They evaluated the currently available research and data on the safety and efficacy of medical marijuana and cannabis-based medicines, and have advised us that due to the lack of randomized, large scale, placebocontrolled clinical studies, scientific evidence is insufficient to reach a conclusion on the safety and/or the efficacy of medical marijuana for the treatment of Tourette Syndrome and Tic Disorders. In the absence of conclusive medical research, they are especially concerned about medical marijuana in the treatment of
children and adolescents. The Tourette Association of America shares that concern.
Medical marijuana is not regulated by the Food and Drug Administration (FDA) and is not sanctioned under federal law. However, at the time of this writing, 33 states and the District of Columbia have legalized medical marijuana to treat specific conditions including those that cause muscle spasms, seizures, and chronic pain. Several states have specifically approved medical marijuana for the treatment of Tourette Syndrome including Arkansas, Illinois, Minnesota, Missouri, New Jersey, and Ohio. Still other states permit individuals to access medical marijuana providing a physician certifies that no other medications have provided relief. Medical marijuana is dispensed by state regulated dispensaries, under the direction of a pharmacist, and only after a physician certifies that a patient meets that state’s criteria.
The absence of federal laws sanctioning medical marijuana nationwide, as well as its classification as a Schedule I drug, precludes large-scale controlled research studies from being conducted at academic/research institutions in America. In Germany, a large placebo-controlled study designed to investigate the efficacy and safety of cannabis in patients with Tourette Syndrome is currently recruiting participants. The TAA supports efforts to allow research on medical marijuana to move forward in this country as well. The TAA also supports a drug schedule re-evaluation for medical marijuana which may open the way for clinical trials to assess the efficacy of potential new medications to treat Tourette Syndrome.
Many members of our community have pervasive and painful tics and co-occurring conditions that are not well controlled by current FDA approved options. While there are three medications the FDA has specifically approved for the treatment of Tourette Syndrome, their side effects are significant and they are no longer considered a first option for treatment. More commonly, FDA approved medications are administered off label to children, adolescents, and adults, often effectively but perhaps equally often with adverse, sometimes significant, side effects. The Tourette Association of America recently conducted an impact survey which found that 47% of adults and 44% of the parents of children with Tourette Syndrome do not feel their or their children’s symptoms are adequately controlled by existing medications. We recognize the need for more effective treatments to improve the quality of life for all people with Tourette Syndrome and Tic Disorders.
The Tourette Association of America supports increased research and large scale controlled clinical trials by increasing funding and access to medical marijuana. Thus far, the TAA has funded 5 research grants in Canada, Israel and the U.S. on medical marijuana and related drugs that target cannabis pathways, but more research is needed. The TAA also supports the inclusion of Tourette Syndrome as an approved condition in states where medical marijuana is available to adults with other intractable and incurable conditions but urges caution.
Members of our community who choose to explore medical marijuana as a treatment option should only do so with close medical guidance and after carefully considering the potential risks and benefits. The Tourette Association of America neither recommends nor prescribes specific medications including FDA approved pharmaceuticals and medical marijuana.